{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T05:49:55Z","timestamp":1776491395166,"version":"3.51.2"},"reference-count":31,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.3892\/ol.2015.3386","type":"journal-article","created":{"date-parts":[[2015,6,17]],"date-time":"2015-06-17T08:32:43Z","timestamp":1434529963000},"page":"1875-1881","source":"Crossref","is-referenced-by-count":4,"title":["RAS\/BRAF mutational status in familial non-medullary thyroid carcinomas: A retrospective study"],"prefix":"10.3892","volume":"10","author":[{"given":"MATTEO","family":"LANDRISCINA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MARIA IOLE","family":"NATALICCHIO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"OLGA","family":"LAMACCHIA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANTONELLA","family":"CONSERVA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANNAMARIA","family":"PISCAZZI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANNA","family":"CIAMPOLILLO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MATTEO","family":"ZINGRILLO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANTONIO","family":"PENNELLA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PANTALEO","family":"BUFO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GIULIA","family":"VITA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RAFFAELE","family":"ANTONETTI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"EUGENIO","family":"MAIORANO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FRANCESCO","family":"GIORGINO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MAURO","family":"CIGNARELLI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,6,17]]},"reference":[{"key":"key20180108100008_b1-ol-0-0-3386","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1089\/thy.2013.0079","article-title":"Familial nonmedullary thyroid carcinoma","volume":"23","author":"Mazeh","year":"2013","journal-title":"Thyroid"},{"key":"key20180108100008_b2-ol-0-0-3386","first-page":"1043","article-title":"Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer?","volume":"128","author":"Alsanea","year":"2000","journal-title":"A multicenter series. Surgery"},{"key":"key20180108100008_b3-ol-0-0-3386","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00268-002-6615-y","article-title":"Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population","volume":"26","author":"Uchino","year":"2002","journal-title":"World J Surg"},{"key":"key20180108100008_b4-ol-0-0-3386","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/thy.2011.0192","article-title":"In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease","volume":"22","author":"Mazeh","year":"2012","journal-title":"Thyroid"},{"key":"key20180108100008_b5-ol-0-0-3386","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1089\/thy.2011.0163","article-title":"The long-term outcomes of the second generation of familial nonmedullary thyroid carcinoma are more aggressive than sporadic cases","volume":"22","author":"Park","year":"2012","journal-title":"Thyroid"},{"key":"key20180108100008_b6-ol-0-0-3386","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/jso.23447","article-title":"Familial history of non-medullary thyroid cancer is an independent prognostic factor for tumor recurrence in younger patients with conventional papillary thyroid carcinoma","volume":"109","author":"Lee","year":"2014","journal-title":"J Surg Oncol"},{"key":"key20180108100008_b7-ol-0-0-3386","doi-asserted-by":"crossref","first-page":"948786","DOI":"10.1155\/2011\/948786","article-title":"Familial papillary thyroid carcinoma: A retrospective analysis","volume":"2011","author":"McDonald","year":"2011","journal-title":"J Oncol"},{"key":"key20180108100008_b8-ol-0-0-3386","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1097\/01.mlg.0000149454.91005.65","article-title":"Familial non-medullary thyroid cancer: A matched-case control study","volume":"114","author":"Maxwell","year":"2004","journal-title":"Laryngoscope"},{"key":"key20180108100008_b9-ol-0-0-3386","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.surg.2008.08.004","article-title":"Biological behavior and prognosis of familial papillary thyroid carcinoma","volume":"145","author":"Ito","year":"2009","journal-title":"Surgery"},{"key":"key20180108100008_b10-ol-0-0-3386","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1089\/thy.2009.0406","article-title":"Clinical characteristics and outcome of familial nonmedullary thyroid cancer: A retrospective controlled study","volume":"21","author":"Robenshtok","year":"2011","journal-title":"Thyroid"},{"key":"key20180108100008_b11-ol-0-0-3386","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1089\/thy.2010.0256","article-title":"Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer","volume":"21","author":"Moses","year":"2011","journal-title":"Thyroid"},{"key":"key20180108100008_b12-ol-0-0-3386","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1530\/EJE-13-0865","article-title":"Familial vs sporadic papillary thyroid carcinoma: A matched-case comparative study thening similar clinical\/prognostic behaviour","volume":"170","author":"Pinto","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"key20180108100008_b13-ol-0-0-3386","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1089\/thy.2013.0694","article-title":"Is familial nonmedullary thyroid carcinoma more aggressive than sporadic nonmedullary thyroid carcinoma?","volume":"24","author":"Malchoff","year":"2014","journal-title":"Thyroid"},{"key":"key20180108100008_b14-ol-0-0-3386","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1089\/thy.2006.16.181","article-title":"On the prevalence of familial nonmedullary thyroid cancer in multiply affected kindreds","volume":"16","author":"Charkes","year":"2006","journal-title":"Thyroid"},{"key":"key20180108100008_b15-ol-0-0-3386","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.1038\/sj.onc.1208822","article-title":"Molecular classification of papillary thyroid carcinoma: Distinct BRAF, RAS, and RET\/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis","volume":"24","author":"Giordano","year":"2005","journal-title":"Oncogene"},{"key":"key20180108100008_b16-ol-0-0-3386","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00268-006-0864-0","article-title":"TNM classification of thyroid carcinoma","volume":"31","author":"Shaha","year":"2007","journal-title":"World J Surg"},{"key":"key20180108100008_b17-ol-0-0-3386","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2217\/fon.13.233","article-title":"Pyrosequencing evaluation of low-frequency KRAS mutant alleles for EGF receptor therapy selection in metastatic colorectal carcinoma","volume":"10","author":"Natalicchio","year":"2014","journal-title":"Future Oncol"},{"key":"key20180108100008_b18-ol-0-0-3386","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.2217\/fon.09.85","article-title":"Diagnostic markers and prognostic factors in thyroid cancer","volume":"5","author":"Vriens","year":"2009","journal-title":"Future Oncol"},{"key":"key20180108100008_b19-ol-0-0-3386","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000345674","article-title":"Clinical behavior and genetics of nonsyndromic, familial nonmedullary thyroid cancer","volume":"41","author":"Bauer","year":"2013","journal-title":"Front Horm Res"},{"key":"key20180108100008_b20-ol-0-0-3386","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1399-0004.2010.01495.x","article-title":"Germline mutation in BRAF codon 600 is compatible with human development: De novo p.V600G mutation identified in a patient with CFC syndrome","volume":"79","author":"Champion","year":"2011","journal-title":"Clin Genet"},{"key":"key20180108100008_b21-ol-0-0-3386","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ng.497","article-title":"A restricted spectrum of NRAS mutations causes Noonan syndrome","volume":"42","author":"Cirstea","year":"2010","journal-title":"Nat Genet"},{"key":"key20180108100008_b22-ol-0-0-3386","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fendo.2012.00061","article-title":"Familial follicular cell-derived thyroid carcinoma","volume":"3","author":"Son","year":"2012","journal-title":"Front Endocrinol (Lausanne)"},{"key":"key20180108100008_b23-ol-0-0-3386","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1365-2265.2009.03699.x","article-title":"The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: Clinical and molecular studies","volume":"72","author":"Muzza","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key20180108100008_b24-ol-0-0-3386","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1210\/jc.2012-2555","article-title":"Interferon-\u03b3 and tumor necrosis factor-\u03b1 sustain secretion of specific CXC chemokines in human thyrocytes: A first step toward a differentiation between autoimmune and tumor-related inflammation?","volume":"98","author":"Rotondi","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180108100008_b25-ol-0-0-3386","first-page":"3449","article-title":"The thyroid gland: A crossroad in inflammation-induced carcinoma?","volume":"17","author":"Bozec","year":"2010","journal-title":"An ongoing debate with new therapeutic potential. Curr Med Chem"},{"key":"key20180108100008_b26-ol-0-0-3386","doi-asserted-by":"crossref","first-page":"e1004123","DOI":"10.1371\/journal.pgen.1004123","article-title":"Identification of novel genetic Loci associated with thyroid peroxidase antibodies and clinical thyroid disease","volume":"10","author":"Medici","year":"2014","journal-title":"PLoS Genet"},{"key":"key20180108100008_b27-ol-0-0-3386","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mce.2010.01.007","article-title":"Molecular prognostic markers in papillary and follicular thyroid cancer: Current status and future directions","volume":"322","author":"Handkiewicz-Junak","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"key20180108100008_b28-ol-0-0-3386","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1089\/thy.2014.0053","article-title":"NRAS codon 61 mutation is associated with distant metastasis in patients with follicular thyroid carcinoma","volume":"24","author":"Jang","year":"2014","journal-title":"Thyroid"},{"key":"key20180108100008_b29-ol-0-0-3386","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1210\/jc.2012-1775","article-title":"The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study","volume":"97","author":"Elisei","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180108100008_b30-ol-0-0-3386","first-page":"3702","article-title":"Does BRAF V600E mutation predict aggressive features in papillary thyroid cancer?","volume":"98","author":"Li","year":"2013","journal-title":"Results from four endocrine surgery centers. J Clin Endocrinol Metab"},{"key":"key20180108100008_b31-ol-0-0-3386","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/cen.12386","article-title":"The BRAF(V600E) mutation in papillary thyroid microcarcinoma: Does the mutation have an impact on clinical outcome?","volume":"80","author":"Walczyk","year":"2014","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2015.3386\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T04:01:19Z","timestamp":1566878479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2015.3386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,17]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,6,17]]},"published-print":{"date-parts":[[2015,9]]}},"alternative-id":["10.3892\/ol.2015.3386"],"URL":"https:\/\/doi.org\/10.3892\/ol.2015.3386","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,17]]}}}